-transparent.png){kind=logo}
In C57 black mice, MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) (30 mg/kg X 2, 20 mg/kg X 15, 30 mg/kg X 15, or 35 mg/kg X 1) depleted DA in both striatum and accumbens but not in frontal cortex, hypothalamus and retina. DA decreases were more pronounced in striatum than in accumbens, were maximal at 2 days, partially reversed later but persisted up to 30 days after treatment. DA depletions in nigra were smaller earlier and maximal later. The study suggests that, in mice, MPTP damages nigrostriatal and mesolimbic projections but spares other DA neurons.
Related Publications
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
October 2007,
Brain research,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
January 2017,
Neurochemistry international,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
December 2004,
Brain research,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
September 2007,
Phytotherapy research : PTR,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
November 2019,
Antioxidants (Basel, Switzerland),
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
May 2007,
Antioxidants & redox signaling,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
January 2008,
Cell biology international,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
February 2001,
Brain research,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
January 2018,
Frontiers in cellular neuroscience,
E Melamed, and
J Rosenthal, and
M Globus, and
O Cohen, and
Y Frucht, and
A Uzzan
August 2008,
Experimental neurology,
